ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global circRNAs Treatment Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-37Z17380
Home | Market Reports | Science| Biological Sciences
Global circRNAs Treatment Market Research Report 2024
BUY CHAPTERS

Global circRNAs Treatment Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-37Z17380
Report
October 2025
Pages:133
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Orna Therapeutics
Torque Bio
Chimera Therapeutics
CirCode
Curemedbio
Sail Biomedicines
Orbital Therapeutics
Therorna Inc.

circRNAs Treatment Market

The global circRNAs Treatment market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Circular RNA (circRNA) is a new type of RNA that is different from traditional linear RNA. It has a closed ring structure and is abundantly present in the eukaryotic transcriptome. Most circRNAs are composed of exon sequences, which are conserved in different species and have expression specificity in tissues and different developmental stages. Because circRNA is insensitive to nucleases, it is more stable than linear RNA, which gives circRNA a clear advantage in the development and application of new clinical diagnostic markers. In addition, recent studies have shown that circRNAs act as miRNA sponges in different species and are called competitive endogenous RNAs (ceRNAs), which can competitively bind to miRNAs and thereby regulate the expression of target genes. This shows that circRNA may play a very important role in disease regulation by competitively binding to disease-related miRNAs.
From a downstream perspective, Infectious Diseases accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
circRNAs Treatment leading manufacturers including Orna Therapeutics, Torque Bio, Chimera Therapeutics, CirCode, Curemedbio, Sail Biomedicines, Orbital Therapeutics, Therorna, etc., dominate supply; the top five capture approximately % of global revenue, with Orna Therapeutics leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global circRNAs Treatment market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of circRNAs Treatment Market Report

Report Metric Details
Report Name circRNAs Treatment Market
Segment by Type
Segment by Application
  • Infectious Diseases
  • Cancer
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Orna Therapeutics, Torque Bio, Chimera Therapeutics, CirCode, Curemedbio, Sail Biomedicines, Orbital Therapeutics, Therorna
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the circRNAs Treatment study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the circRNAs Treatment Market report?

Ans: The main players in the circRNAs Treatment Market are Orna Therapeutics, Torque Bio, Chimera Therapeutics, CirCode, Curemedbio, Sail Biomedicines, Orbital Therapeutics, Therorna

What are the Application segmentation covered in the circRNAs Treatment Market report?

Ans: The Applications covered in the circRNAs Treatment Market report are Infectious Diseases, Cancer, Others

What are the Type segmentation covered in the circRNAs Treatment Market report?

Ans: The Types covered in the circRNAs Treatment Market report are Preventive Medicine, Medicine

Recommended Reports

RNA Technologies

Gene Therapy

RNA-Based Drugs

1 Study Coverage
1.1 Introduction to circRNAs Treatment: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global circRNAs Treatment Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Preventive Medicine
1.2.3 Medicine
1.3 Market Segmentation by Application
1.3.1 Global circRNAs Treatment Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Infectious Diseases
1.3.3 Cancer
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global circRNAs Treatment Revenue Estimates and Forecasts 2020-2031
2.2 Global circRNAs Treatment Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global circRNAs Treatment Sales Estimates and Forecasts 2020-2031
2.4 Global circRNAs Treatment Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global circRNAs Treatment Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global circRNAs Treatment Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Preventive Medicine Market Size by Manufacturers
3.5.2 Medicine Market Size by Manufacturers
3.6 Global circRNAs Treatment Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global circRNAs Treatment Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global circRNAs Treatment Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global circRNAs Treatment Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global circRNAs Treatment Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America circRNAs Treatment Sales and Revenue by Type (2020-2031)
6.4 North America circRNAs Treatment Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America circRNAs Treatment Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe circRNAs Treatment Sales and Revenue by Type (2020-2031)
7.4 Europe circRNAs Treatment Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe circRNAs Treatment Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific circRNAs Treatment Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific circRNAs Treatment Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific circRNAs Treatment Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America circRNAs Treatment Sales and Revenue by Type (2020-2031)
9.4 Central and South America circRNAs Treatment Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America circRNAs Treatment Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa circRNAs Treatment Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa circRNAs Treatment Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa circRNAs Treatment Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Orna Therapeutics
11.1.1 Orna Therapeutics Corporation Information
11.1.2 Orna Therapeutics Business Overview
11.1.3 Orna Therapeutics circRNAs Treatment Product Models, Descriptions and Specifications
11.1.4 Orna Therapeutics circRNAs Treatment Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Orna Therapeutics circRNAs Treatment Sales by Product in 2024
11.1.6 Orna Therapeutics circRNAs Treatment Sales by Application in 2024
11.1.7 Orna Therapeutics circRNAs Treatment Sales by Geographic Area in 2024
11.1.8 Orna Therapeutics circRNAs Treatment SWOT Analysis
11.1.9 Orna Therapeutics Recent Developments
11.2 Torque Bio
11.2.1 Torque Bio Corporation Information
11.2.2 Torque Bio Business Overview
11.2.3 Torque Bio circRNAs Treatment Product Models, Descriptions and Specifications
11.2.4 Torque Bio circRNAs Treatment Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Torque Bio circRNAs Treatment Sales by Product in 2024
11.2.6 Torque Bio circRNAs Treatment Sales by Application in 2024
11.2.7 Torque Bio circRNAs Treatment Sales by Geographic Area in 2024
11.2.8 Torque Bio circRNAs Treatment SWOT Analysis
11.2.9 Torque Bio Recent Developments
11.3 Chimera Therapeutics
11.3.1 Chimera Therapeutics Corporation Information
11.3.2 Chimera Therapeutics Business Overview
11.3.3 Chimera Therapeutics circRNAs Treatment Product Models, Descriptions and Specifications
11.3.4 Chimera Therapeutics circRNAs Treatment Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Chimera Therapeutics circRNAs Treatment Sales by Product in 2024
11.3.6 Chimera Therapeutics circRNAs Treatment Sales by Application in 2024
11.3.7 Chimera Therapeutics circRNAs Treatment Sales by Geographic Area in 2024
11.3.8 Chimera Therapeutics circRNAs Treatment SWOT Analysis
11.3.9 Chimera Therapeutics Recent Developments
11.4 CirCode
11.4.1 CirCode Corporation Information
11.4.2 CirCode Business Overview
11.4.3 CirCode circRNAs Treatment Product Models, Descriptions and Specifications
11.4.4 CirCode circRNAs Treatment Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 CirCode circRNAs Treatment Sales by Product in 2024
11.4.6 CirCode circRNAs Treatment Sales by Application in 2024
11.4.7 CirCode circRNAs Treatment Sales by Geographic Area in 2024
11.4.8 CirCode circRNAs Treatment SWOT Analysis
11.4.9 CirCode Recent Developments
11.5 Curemedbio
11.5.1 Curemedbio Corporation Information
11.5.2 Curemedbio Business Overview
11.5.3 Curemedbio circRNAs Treatment Product Models, Descriptions and Specifications
11.5.4 Curemedbio circRNAs Treatment Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Curemedbio circRNAs Treatment Sales by Product in 2024
11.5.6 Curemedbio circRNAs Treatment Sales by Application in 2024
11.5.7 Curemedbio circRNAs Treatment Sales by Geographic Area in 2024
11.5.8 Curemedbio circRNAs Treatment SWOT Analysis
11.5.9 Curemedbio Recent Developments
11.6 Sail Biomedicines
11.6.1 Sail Biomedicines Corporation Information
11.6.2 Sail Biomedicines Business Overview
11.6.3 Sail Biomedicines circRNAs Treatment Product Models, Descriptions and Specifications
11.6.4 Sail Biomedicines circRNAs Treatment Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Sail Biomedicines Recent Developments
11.7 Orbital Therapeutics
11.7.1 Orbital Therapeutics Corporation Information
11.7.2 Orbital Therapeutics Business Overview
11.7.3 Orbital Therapeutics circRNAs Treatment Product Models, Descriptions and Specifications
11.7.4 Orbital Therapeutics circRNAs Treatment Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Orbital Therapeutics Recent Developments
11.8 Therorna
11.8.1 Therorna Corporation Information
11.8.2 Therorna Business Overview
11.8.3 Therorna circRNAs Treatment Product Models, Descriptions and Specifications
11.8.4 Therorna circRNAs Treatment Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Therorna Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 circRNAs Treatment Industry Chain
12.2 circRNAs Treatment Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 circRNAs Treatment Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 circRNAs Treatment Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 circRNAs Treatment Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global circRNAs Treatment Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Orna Therapeutics
Torque Bio
Chimera Therapeutics
CirCode
Curemedbio
Sail Biomedicines
Orbital Therapeutics
Therorna Inc.
List of Tables
 Table 1. Global circRNAs Treatment Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global circRNAs Treatment Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global circRNAs Treatment Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global circRNAs Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global circRNAs Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global circRNAs Treatment Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Dose)
 Table 7. Global circRNAs Treatment Sales by Region (2020-2025) & (K Dose)
 Table 8. Global circRNAs Treatment Sales by Region (2026-2031) & (K Dose)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global circRNAs Treatment Sales by Manufacturers (2020-2025) & (K Dose)
 Table 11. Global circRNAs Treatment Sales Share by Manufacturers (2020-2025)
 Table 12. Global circRNAs Treatment Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global circRNAs Treatment Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global circRNAs Treatment by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in circRNAs Treatment as of 2024)
 Table 16. Global circRNAs Treatment Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global circRNAs Treatment Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Dose)
 Table 18. Key Manufacturers circRNAs Treatment Manufacturing Base and Headquarters
 Table 19. Global circRNAs Treatment Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global circRNAs Treatment Sales by Type (2020-2025) & (K Dose)
 Table 23. Global circRNAs Treatment Sales by Type (2026-2031) & (K Dose)
 Table 24. Global circRNAs Treatment Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global circRNAs Treatment Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global circRNAs Treatment ASP by Type (2020-2031) & (US$/Dose)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global circRNAs Treatment Sales by Application (2020-2025) & (K Dose)
 Table 29. Global circRNAs Treatment Sales by Application (2026-2031) & (K Dose)
 Table 30. circRNAs Treatment High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global circRNAs Treatment Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global circRNAs Treatment Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global circRNAs Treatment ASP by Application (2020-2031) & (US$/Dose)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America circRNAs Treatment Growth Accelerators and Market Barriers
 Table 37. North America circRNAs Treatment Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America circRNAs Treatment Sales (K Dose) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe circRNAs Treatment Growth Accelerators and Market Barriers
 Table 40. Europe circRNAs Treatment Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe circRNAs Treatment Sales (K Dose) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific circRNAs Treatment Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific circRNAs Treatment Sales (K Dose) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific circRNAs Treatment Growth Accelerators and Market Barriers
 Table 45. Southeast Asia circRNAs Treatment Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America circRNAs Treatment Investment Opportunities and Key Challenges
 Table 47. Central and South America circRNAs Treatment Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa circRNAs Treatment Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa circRNAs Treatment Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Orna Therapeutics Corporation Information
 Table 51. Orna Therapeutics Description and Major Businesses
 Table 52. Orna Therapeutics Product Models, Descriptions and Specifications
 Table 53. Orna Therapeutics Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 54. Orna Therapeutics Sales Value Proportion by Product in 2024
 Table 55. Orna Therapeutics Sales Value Proportion by Application in 2024
 Table 56. Orna Therapeutics Sales Value Proportion by Geographic Area in 2024
 Table 57. Orna Therapeutics circRNAs Treatment SWOT Analysis
 Table 58. Orna Therapeutics Recent Developments
 Table 59. Torque Bio Corporation Information
 Table 60. Torque Bio Description and Major Businesses
 Table 61. Torque Bio Product Models, Descriptions and Specifications
 Table 62. Torque Bio Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 63. Torque Bio Sales Value Proportion by Product in 2024
 Table 64. Torque Bio Sales Value Proportion by Application in 2024
 Table 65. Torque Bio Sales Value Proportion by Geographic Area in 2024
 Table 66. Torque Bio circRNAs Treatment SWOT Analysis
 Table 67. Torque Bio Recent Developments
 Table 68. Chimera Therapeutics Corporation Information
 Table 69. Chimera Therapeutics Description and Major Businesses
 Table 70. Chimera Therapeutics Product Models, Descriptions and Specifications
 Table 71. Chimera Therapeutics Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 72. Chimera Therapeutics Sales Value Proportion by Product in 2024
 Table 73. Chimera Therapeutics Sales Value Proportion by Application in 2024
 Table 74. Chimera Therapeutics Sales Value Proportion by Geographic Area in 2024
 Table 75. Chimera Therapeutics circRNAs Treatment SWOT Analysis
 Table 76. Chimera Therapeutics Recent Developments
 Table 77. CirCode Corporation Information
 Table 78. CirCode Description and Major Businesses
 Table 79. CirCode Product Models, Descriptions and Specifications
 Table 80. CirCode Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 81. CirCode Sales Value Proportion by Product in 2024
 Table 82. CirCode Sales Value Proportion by Application in 2024
 Table 83. CirCode Sales Value Proportion by Geographic Area in 2024
 Table 84. CirCode circRNAs Treatment SWOT Analysis
 Table 85. CirCode Recent Developments
 Table 86. Curemedbio Corporation Information
 Table 87. Curemedbio Description and Major Businesses
 Table 88. Curemedbio Product Models, Descriptions and Specifications
 Table 89. Curemedbio Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 90. Curemedbio Sales Value Proportion by Product in 2024
 Table 91. Curemedbio Sales Value Proportion by Application in 2024
 Table 92. Curemedbio Sales Value Proportion by Geographic Area in 2024
 Table 93. Curemedbio circRNAs Treatment SWOT Analysis
 Table 94. Curemedbio Recent Developments
 Table 95. Sail Biomedicines Corporation Information
 Table 96. Sail Biomedicines Description and Major Businesses
 Table 97. Sail Biomedicines Product Models, Descriptions and Specifications
 Table 98. Sail Biomedicines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 99. Sail Biomedicines Recent Developments
 Table 100. Orbital Therapeutics Corporation Information
 Table 101. Orbital Therapeutics Description and Major Businesses
 Table 102. Orbital Therapeutics Product Models, Descriptions and Specifications
 Table 103. Orbital Therapeutics Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 104. Orbital Therapeutics Recent Developments
 Table 105. Therorna Corporation Information
 Table 106. Therorna Description and Major Businesses
 Table 107. Therorna Product Models, Descriptions and Specifications
 Table 108. Therorna Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 109. Therorna Recent Developments
 Table 110. Key Raw Materials Distribution
 Table 111. Raw Materials Key Suppliers
 Table 112. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 113. Milestones in Production Technology Evolution
 Table 114. Distributors List
 Table 115. Market Trends and Market Evolution
 Table 116. Market Drivers and Opportunities
 Table 117. Market Challenges, Risks, and Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources


List of Figures
 Figure 1. circRNAs Treatment Product Picture
 Figure 2. Global circRNAs Treatment Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Preventive Medicine Product Picture
 Figure 4. Medicine Product Picture
 Figure 5. Global circRNAs Treatment Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Infectious Diseases
 Figure 7. Cancer
 Figure 8. Others
 Figure 9. circRNAs Treatment Report Years Considered
 Figure 10. Global circRNAs Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global circRNAs Treatment Revenue (2020-2031) & (US$ Million)
 Figure 12. Global circRNAs Treatment Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 13. Global circRNAs Treatment Revenue Market Share by Region (2020-2031)
 Figure 14. Global circRNAs Treatment Sales (2020-2031) & (K Dose)
 Figure 15. Global circRNAs Treatment Sales (CAGR) by Region (2020-2031) (K Dose)
 Figure 16. Global circRNAs Treatment Sales Market Share by Region (2020-2031)
 Figure 17. Top 5 and Top 10 Manufacturers circRNAs Treatment Sales Volume Market Share in 2024
 Figure 18. Global circRNAs Treatment Revenue Market Share Ranking (2024)
 Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 20. Preventive Medicine Revenue Market Share by Manufacturer in 2024
 Figure 21. Medicine Revenue Market Share by Manufacturer in 2024
 Figure 22. Global circRNAs Treatment Sales Market Share by Type (2020-2031)
 Figure 23. Global circRNAs Treatment Revenue Market Share by Type (2020-2031)
 Figure 24. Global circRNAs Treatment Sales Market Share by Application (2020-2031)
 Figure 25. Global circRNAs Treatment Revenue Market Share by Application (2020-2031)
 Figure 26. North America circRNAs Treatment Sales YoY (2020-2031) & (K Dose)
 Figure 27. North America circRNAs Treatment Revenue YoY (2020-2031) & (US$ Million)
 Figure 28. North America Top 5 Manufacturers circRNAs Treatment Sales Revenue (US$ Million) in 2024
 Figure 29. North America circRNAs Treatment Sales Volume (K Dose) by Type (2020- 2031)
 Figure 30. North America circRNAs Treatment Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 31. North America circRNAs Treatment Sales Volume (K Dose) by Application (2020-2031)
 Figure 32. North America circRNAs Treatment Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 33. US circRNAs Treatment Revenue (2020-2031) & (US$ Million)
 Figure 34. Canada circRNAs Treatment Revenue (2020-2031) & (US$ Million)
 Figure 35. Mexico circRNAs Treatment Revenue (2020-2031) & (US$ Million)
 Figure 36. Europe circRNAs Treatment Sales YoY (2020-2031) & (K Dose)
 Figure 37. Europe circRNAs Treatment Revenue YoY (2020-2031) & (US$ Million)
 Figure 38. Europe Top 5 Manufacturers circRNAs Treatment Sales Revenue (US$ Million) in 2024
 Figure 39. Europe circRNAs Treatment Sales Volume (K Dose) by Type (2020-2031)
 Figure 40. Europe circRNAs Treatment Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 41. Europe circRNAs Treatment Sales Volume (K Dose) by Application (2020-2031)
 Figure 42. Europe circRNAs Treatment Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 43. Germany circRNAs Treatment Revenue (2020-2031) & (US$ Million)
 Figure 44. France circRNAs Treatment Revenue (2020-2031) & (US$ Million)
 Figure 45. U.K. circRNAs Treatment Revenue (2020-2031) & (US$ Million)
 Figure 46. Italy circRNAs Treatment Revenue (2020-2031) & (US$ Million)
 Figure 47. Russia circRNAs Treatment Revenue (2020-2031) & (US$ Million)
 Figure 48. Asia-Pacific circRNAs Treatment Sales YoY (2020-2031) & (K Dose)
 Figure 49. Asia-Pacific circRNAs Treatment Revenue YoY (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Top 8 Manufacturers circRNAs Treatment Sales Revenue (US$ Million) in 2024
 Figure 51. Asia-Pacific circRNAs Treatment Sales Volume (K Dose) by Type (2020- 2031)
 Figure 52. Asia-Pacific circRNAs Treatment Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 53. Asia-Pacific circRNAs Treatment Sales Volume (K Dose) by Application (2020-2031)
 Figure 54. Asia-Pacific circRNAs Treatment Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 55. Indonesia circRNAs Treatment Revenue (2020-2031) & (US$ Million)
 Figure 56. Japan circRNAs Treatment Revenue (2020-2031) & (US$ Million)
 Figure 57. South Korea circRNAs Treatment Revenue (2020-2031) & (US$ Million)
 Figure 58. China Taiwan circRNAs Treatment Revenue (2020-2031) & (US$ Million)
 Figure 59. India circRNAs Treatment Revenue (2020-2031) & (US$ Million)
 Figure 60. Central and South America circRNAs Treatment Sales YoY (2020-2031) & (K Dose)
 Figure 61. Central and South America circRNAs Treatment Revenue YoY (2020-2031) & (US$ Million)
 Figure 62. Central and South America Top 5 Manufacturers circRNAs Treatment Sales Revenue (US$ Million) in 2024
 Figure 63. Central and South America circRNAs Treatment Sales Volume (K Dose) by Type (2021-2031)
 Figure 64. Central and South America circRNAs Treatment Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 65. Central and South America circRNAs Treatment Sales Volume (K Dose) by Application (2020-2031)
 Figure 66. Central and South America circRNAs Treatment Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 67. Brazil circRNAs Treatment Revenue (2020-2025) & (US$ Million)
 Figure 68. Argentina circRNAs Treatment Revenue (2020-2025) & (US$ Million)
 Figure 69. Middle East, and Africa circRNAs Treatment Sales YoY (2020-2031) & (K Dose)
 Figure 70. Middle East and Africa circRNAs Treatment Revenue YoY (2020-2031) & (US$ Million)
 Figure 71. Middle East and Africa Top 5 Manufacturers circRNAs Treatment Sales Revenue (US$ Million) in 2024
 Figure 72. Middle East and Africa circRNAs Treatment Sales Volume (K Dose) by Type (2021-2031)
 Figure 73. South America circRNAs Treatment Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 74. Middle East and Africa circRNAs Treatment Sales Volume (K Dose) by Application (2020-2031)
 Figure 75. Middle East and Africa circRNAs Treatment Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 76. GCC Countries circRNAs Treatment Revenue (2020-2025) & (US$ Million)
 Figure 77. Turkey circRNAs Treatment Revenue (2020-2025) & (US$ Million)
 Figure 78. Egypt circRNAs Treatment Revenue (2020-2025) & (US$ Million)
 Figure 79. South Africa circRNAs Treatment Revenue (2020-2025) & (US$ Million)
 Figure 80. circRNAs Treatment Industry Chain Mapping
 Figure 81. Regional circRNAs Treatment Manufacturing Base Distribution (%)
 Figure 82. Global circRNAs Treatment Production Market Share by Region (2020-2031)
 Figure 83. circRNAs Treatment Production Process
 Figure 84. Regional circRNAs Treatment Production Cost Structure
 Figure 85. Channels of Distribution (Direct Vs Distribution)
 Figure 86. Bottom-up and Top-down Approaches for This Report
 Figure 87. Data Triangulation
 Figure 88. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Circular RNA Therapy Market Research Report 2024
Global Circular RNA Research Market Insights Forecast to 2030
Global CircRNA Synthesis Service Market Research Report 2024
Global Exogenous Circular RNA Synthesis Service Market Research Report 2025
Global Circular mRNA Drugs Market Research Report 2024
Global ircular RNA Synthesis Service Market Research Report 2024
Global Circular RNA Drugs Market Research Report 2025
Global Circular RNA Sequencing Market Insights Forecast to 2030
Global Circular RNA Synthesis Kit Market Research Report 2024
Global circRNA Technology Market Research Report 2024
Global Targeted lncRNA Single Cell Sequencing Market Research Report 2024
Global MicroRNA Reverse Transcription Market Research Report 2024
Global Long Non coding RNA Sequencing lncRNA seq Market Research Report 2024
Global miRNA Sequencing and Assay Market Insights Forecast to 2030
Global MicroRNA Market Research Report 2024
Global miRNA Microarray Kits Reagents Market Research Report 2024
Global MicroRNA Sequencing miRNA Seq Market Research Report 2024
Global miRNA Tools and Services Market Research Report 2024
Global RNA Vaccines Market Insights Forecast to 2030
Global MicroRNA Sponge Service Market Research Report 2024

RELATED REPORTS

Global Cell-free DNA Testing Service Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18B20127
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global cfDNA Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36H20013
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Strong Cation Exchange Agarose Gel Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7C20305
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Deoxyadenosine Triphosphate Solution Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13N20234
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions